Calithera Biosciences, Inc. Quarterly Debt-to-equity in % from Q2 2015 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Calithera Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q2 2015 to Q4 2022.
  • Calithera Biosciences, Inc. Debt-to-equity for the quarter ending December 31, 2022 was 53.2 %, a 121% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 53.2 +29.1 +121% Dec 31, 2022
Q3 2022 73.8 +54 +272% Sep 30, 2022
Q2 2022 47.2 +27.4 +138% Jun 30, 2022
Q1 2022 36.1 +17.4 +93.1% Mar 31, 2022
Q4 2021 24.1 +5.52 +29.8% Dec 31, 2021
Q3 2021 19.8 +2.06 +11.6% Sep 30, 2021
Q2 2021 19.8 +1.9 +10.6% Jun 30, 2021
Q1 2021 18.7 -0.35 -1.84% Mar 31, 2021
Q4 2020 18.6 -2.09 -10.1% Dec 31, 2020
Q3 2020 17.8 -1.45 -7.55% Sep 30, 2020
Q2 2020 17.9 +2.03 +12.8% Jun 30, 2020
Q1 2020 19.1 +6.35 +50% Mar 31, 2020
Q4 2019 20.6 +8.03 +63.7% Dec 31, 2019
Q3 2019 19.2 +2.61 +15.7% Sep 30, 2019
Q2 2019 15.9 -6.01 -27.4% Jun 30, 2019
Q1 2019 12.7 -15.1 -54.3% Mar 31, 2019
Q4 2018 12.6 -18.7 -59.8% Dec 31, 2018
Q3 2018 16.6 -13.7 -45.1% Sep 30, 2018
Q2 2018 21.9 -5.84 -21.1% Jun 30, 2018
Q1 2018 27.8 +5.45 +24.4% Mar 31, 2018
Q4 2017 31.3 +22.9 +272% Dec 31, 2017
Q3 2017 30.2 +22.9 +313% Sep 30, 2017
Q2 2017 27.7 +20.8 +299% Jun 30, 2017
Q1 2017 22.3 +16.2 +265% Mar 31, 2017
Q4 2016 8.42 +2.94 +53.6% Dec 31, 2016
Q3 2016 7.32 +2.15 +41.6% Sep 30, 2016
Q2 2016 6.96 +0.01 +0.14% Jun 30, 2016
Q1 2016 6.13 Mar 31, 2016
Q4 2015 5.49 Dec 31, 2015
Q3 2015 5.17 Sep 30, 2015
Q2 2015 6.95 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.